Dr. Reddy’s Laboratories and Argenta Discovery Ltd. have entered into an agreement for the joint development and commercialization of a novel approach to the treatment of Chronic Obstructive Pulmonary Disease (COPD). Under the terms of the agreement, Dr. Reddy’s and Argenta will collaborate to identify clinical candidates from a certain class of Dr. Reddy’s compounds for use as potential treatments for COPD. Both the parties will jointly develop the selected candidates from the...